Imunon, Inc. Faces Delisting Concerns, Director Changes
Ticker: IMNN · Form: 8-K · Filed: Jul 14, 2025 · CIK: 749647
| Field | Detail |
|---|---|
| Company | Imunon, INC. (IMNN) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, corporate-governance, regulatory
TL;DR
Imunon's in trouble - might get delisted, board shake-up happening.
AI Summary
Imunon, Inc. filed an 8-K on July 14, 2025, reporting a notice of delisting or failure to satisfy continued listing rules, as well as changes in directors and officers. The company, formerly known as Celsion Corp, is incorporated in Delaware and has its principal business address in Lawrenceville, NJ.
Why It Matters
This filing indicates potential financial distress or non-compliance with exchange rules, which could significantly impact the company's stock trading and investor confidence.
Risk Assessment
Risk Level: high — The notice of delisting or failure to satisfy continued listing rules is a significant red flag for the company's operational and financial health.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Lawrenceville, NJ (location) — Business address
FAQ
What specific listing rule has Imunon, Inc. failed to satisfy?
The filing does not specify the exact listing rule that Imunon, Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 11, 2025.
What were Imunon, Inc.'s former names?
Imunon, Inc. was formerly known as Celsion Corp and Cheung Laboratories Inc.
What is Imunon, Inc.'s Standard Industrial Classification (SIC) code?
Imunon, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What other items are reported in this 8-K filing besides the delisting notice?
This 8-K filing also reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding Imunon, Inc. (IMNN).